The beneficial role of retinoids in glomerular disease

Frontiers in Medicine

Volumn 2, Issue MAR, 2015, Pages 16-

  Mallipattu, Sandeep K ^a   He, John Cijiang ^b,c  

^a STONY BROOK UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

FSGS; HIVAN; Podocytes; Retinoic acid; Retinoic acid receptor alpha; Retinol binding proteins

Indexed keywords

EID: 85052907374     PISSN: None     EISSN: 2296858X     Source Type: Journal    
DOI: 10.3389/fmed.2015.00016     Document Type: Short Survey

References (42)

1. Orfanos CE, Ehlert R, Gollnick H. The retinoids. A review of their clinical pharmacology and therapeutic use. Drugs (1987) 34(4):459-503. doi: 10.2165/00003495-198734040-00003
2. Niederreither K, Dolle P. Retinoic acid in development: towards an integrated view. Nat Rev Genet (2008) 9(7):541-53. doi:10.1038/nrg2340
3. Mongan NP, Gudas LJ. Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation (2007) 75(9):853-70. doi:10.1111/j.1432-0436.2007.00206.x
4. Xu Q, Lucio-Cazana J, Kitamura M, Ruan X, Fine LG, Norman JT. Retinoids in nephrology: promises and pitfalls. Kidney Int (2004) 66(6):2119-31. doi:10.1111/j.1523-1755.2004.66002.x
5. Gronemeyer H, Miturski R. Molecular mechanisms of retinoid action. Cell Mol Biol Lett (2001) 6(1):3-52.
6. Evans TR, Kaye SB. Retinoids: present role and future potential. Br J Cancer (1999) 80(1-2):1-8. doi:10.1038/sj.bjc.6690312
7. Merlet-Benichou C, Vilar J, Lelievre-Pegorier M, Gilbert T. Role of retinoids in renal development: pathophysiological implication. Curr Opin Nephrol Hypertens (1999) 8(1):39-43. doi:10.1097/00041552-199901000-00007
8. Mendelsohn C, Batourina E, Fung S, Gilbert T, Dodd J. Stromal cells mediate retinoid-dependent functions essential for renal development. Development (1999) 126(6):1139-48.
9. Batourina E, Gim S, Bello N, Shy M, Clagett-Dame M, Srinivas S, et al. Vitamin A controls epithelial/mesenchymal interactions through Ret expression. Nat Genet (2001) 27(1):74-8. doi:10.1038/83792
10. Srinivas S, Wu Z, Chen CM, D'Agati V, Costantini F. Dominant effects of RET receptor misexpression and ligand-independent RET signaling on ureteric bud development. Development (1999) 126(7):1375-86.
11. El Kares R, Manolescu DC, Lakhal-Chaieb L, Montpetit A, Zhang Z, Bhat PV, et al. A human ALDH1A2 gene variant is associated with increased newborn kidney size and serum retinoic acid. Kidney Int (2010) 78(1):96-102. doi:10.1038/ki.2010.101
12. Niederreither K, Subbarayan V, Dolle P, Chambon P. Embryonic retinoic acid synthesis is essential for early mouse post-implantation development. Nat Genet (1999) 21(4):444-8. doi:10.1038/7788
13. Niederreither K, Vermot J, Schuhbaur B, Chambon P, Dolle P. Retinoic acid synthesis and hindbrain patterning in the mouse embryo. Development (2000) 127(1):75-85.
14. Barisoni L, Kriz W, Mundel P, D'Agati V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol (1999) 10(1):51-61.
15. Barisoni L, Bruggeman LA, Mundel P, D'Agati VD, Klotman PE. HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney Int (2000) 58(1):173-81. doi:10.1046/j.1523-1755.2000.00152.x
16. Oseto S, Moriyama T, Kawada N, Nagatoya K, Takeji M, Ando A, et al. Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis. Kidney Int (2003) 64(4):1241-52. doi:10.1046/j.1523-1755.2003.00219.x
17. Vaughan MR, Pippin JW, Griffin SV, Krofft R, Fleet M, Haseley L, et al. ATRA induces podocyte differentiation and alters nephrin and podocin expression in vitro and in vivo. Kidney Int (2005) 68(1):133-44. doi:10.1111/j.1523-1755.2005.00387.x
18. He JC, Lu TC, Fleet M, Sunamoto M, Husain M, Fang W, et al. Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway. J Am Soc Nephrol (2007) 18(1):93-102. doi:10.1681/ASN.2006070727
19. Lehrke I, Schaier M, Schade K, Morath C, Waldherr R, Ritz E, et al. Retinoid receptor-specific agonists alleviate experimental glomerulonephritis. Am J Physiol Renal Physiol (2002) 282(4):F741-51. doi:10.1152/ajprenal.00026.2001
20. Lu TC, Wang Z, Feng X, Chuang P, Fang W, Chen Y, et al. Retinoic acid utilizes CREB and USF1 in a transcriptional feed-forward loop in order to stimulate MKP1 expression in human immunodeficiency virus-infected podocytes. Mol Cell Biol (2008) 28(18):5785-94. doi:10.1128/MCB.00245-08
21. Ratnam KK, Feng X, Chuang PY, Verma V, Lu TC, Wang J, et al. Role of the retinoic acid receptor-alpha in HIV-associated nephropathy. Kidney Int (2011) 79(6):624-34. doi:10.1038/ki.2010.470
22. Zhong Y, Wu Y, Liu R, Deng Y, Mallipattu SK, Klotman PE, et al. Roflumilast enhances the renal protective effects of retinoids in an HIV-1 transgenic mouse model of rapidly progressive renal failure. Kidney Int (2012) 81(9):856-64. doi:10.1038/ki.2011.467
23. Cohen CD, Klingenhoff A, Boucherot A, Nitsche A, Henger A, Brunner B, et al. Comparative promoter analysis allows de novo identification of specialized cell junction-associated proteins. Proc Natl Acad Sci U S A (2006) 103(15):5682-7. doi:10.1073/pnas.0511257103
24. Mallipattu SK, Liu R, Zheng F, Narla G, Ma'ayan A, Dikman S, et al. Kruppel-like factor 15 (KLF15) is a key regulator of podocyte differentiation. J Biol Chem (2012) 287(23):19122-35. doi:10.1074/jbc.M112.345983
25. McConnell BB, Yang VW. Mammalian Kruppel-like factors in health and diseases. Physiol Rev (2010) 90(4):1337-81. doi:10.1152/physrev.00058.2009
26. Mori T, Sakaue H, Iguchi H, Gomi H, Okada Y, Takashima Y, et al. Role of Kruppel-like factor 15 (KLF15) in transcriptional regulation of adipogenesis. J Biol Chem (2005) 280(13):12867-75. doi:10.1074/jbc.M410515200
27. Albaqumi M, Barisoni L. Current views on collapsing glomerulopathy. J Am Soc Nephrol (2008) 19(7):1276-81. doi:10.1681/ASN.2007080926
28. Dijkman HB, Weening JJ, Smeets B, Verrijp KC, van Kuppevelt TH, Assmann KK, et al. Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. Kidney Int (2006) 70(2):338-44. doi:10.1038/sj.ki.5001574
29. Smeets B, Uhlig S, Fuss A, Mooren F, Wetzels JF, Floege J, et al. Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J Am Soc Nephrol (2009) 20(12):2604-15. doi:10.1681/ASN.2009010122
30. Zhang J, Pippin JW, Vaughan MR, Krofft RD, Taniguchi Y, Romagnani P, et al. Retinoids augment the expression of podocyte proteins by glomerular parietal epithelial cells in experimental glomerular disease. Nephron Exp Nephrol (2012) 121(1-2):e23-37. doi:10.1159/000342808000342808
31. Peired A, Angelotti ML, Ronconi E, la Marca G, Mazzinghi B, Sisti A, et al. Proteinuria impairs podocyte regeneration by sequestering retinoic acid. J Am Soc Nephrol (2013) 24(11):1756-68. doi:10.1681/ASN.2012090950
32. Suzuki A, Ito T, Imai E, Yamato M, Iwatani H, Kawachi H, et al. Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats. J Am Soc Nephrol (2003) 14(4):981-91. doi:10.1097/01.ASN.0000057857.66268.8F
33. Li X, Dai Y, Chuang PY, He JC. Induction of retinol dehydrogenase 9 expression in podocytes attenuates kidney injury. J Am Soc Nephrol (2014) 25(9):1933-41. doi:10.1681/ASN.2013111150
34. Han SY, So GA, Jee YH, Han KH, Kang YS, Kim HK, et al. Effect of retinoic acid in experimental diabetic nephropathy. Immunol Cell Biol (2004) 82(6):568-76. doi:10.1111/j.1440-1711.2004.01287.x
35. Na SY, Kang BY, Chung SW, Han SJ, Ma X, Trinchieri G, et al. Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB. J Biol Chem (1999) 274(12):7674-80. doi:10.1074/jbc.274.12.7674
36. Moreno-Manzano V, Mampaso F, Sepulveda-Munoz JC, Alique M, Chen S, Ziyadeh FN, et al. Retinoids as a potential treatment for experimental puromycin-induced nephrosis. Br J Pharmacol (2003) 139(4):823-31. doi:10.1038/sj.bjp.0705311
37. Kinoshita K, Yoo BS, Nozaki Y, Sugiyama M, Ikoma S, Ohno M, et al. Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F1 mice. J Immunol (2003) 170(11):5793-8. doi:10.4049/jimmunol.170.11.5793
38. Perez de Lema G, Lucio-Cazana FJ, Molina A, Luckow B, Schmid H, de Wit C, et al. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease. Kidney Int (2004) 66(3):1018-28. doi:10.1111/j.1523-1755.2004.00850.x
39. Roszer T, Menendez-Gutierrez MP, Lefterova MI, Alameda D, Nunez V, Lazar MA, et al. Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency. J Immunol (2011) 186(1):621-31. doi:10.4049/jimmunol.1002230
40. Okamura M, Takano Y, Saito Y, Yao J, Kitamura M. Induction of nephrin gene expression by selective cooperation of the retinoic acid receptor and the vitamin D receptor. Nephrol Dial Transplant (2009) 24(10):3006-12. doi:10.1093/ndt/gfp243
41. Wagner J, Dechow C, Morath C, Lehrke I, Amann K, Waldherr R, et al. Retinoic acid reduces glomerular injury in a rat model of glomerular damage. J Am Soc Nephrol (2000) 11(8):1479-87.
42. Zhong Y, Wu Y, Liu R, Li Z, Chen Y, Evans T, et al. Novel retinoic acid receptor alpha agonists for treatment of kidney disease. PLoS One (2011) 6(11):e27945. doi:10.1371/journal.pone.0027945